Research Topics
| J C KingSummaryAffiliation: University of Maryland Country: USA Publications
|
Detail Information
Publications
Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adultsJ C King
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA
J Infect Dis 181:725-8. 2000..The data suggest that inadvertent vaccination with LAIV in relatively asymptomatic HIV-infected adults would not be associated with frequent significant adverse events...
Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virusJ C King
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
J Infect Dis 181:1817-21. 2000..Heterologous, noninfecting group seroresponses were detected frequently (72%) in the paired serum samples from these 4 homologous group seroresponders...
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Pediatr Infect Dis J 20:1124-31. 2001..To assess the safety of live, attenuated influenza vaccine (LAIV) administered to relatively asymptomatic or mildly symptomatic HIV-infected children and non-HIV-infected children...
